DK331881A - Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte deraf - Google Patents
Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte derafInfo
- Publication number
- DK331881A DK331881A DK331881A DK331881A DK331881A DK 331881 A DK331881 A DK 331881A DK 331881 A DK331881 A DK 331881A DK 331881 A DK331881 A DK 331881A DK 331881 A DK331881 A DK 331881A
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- procedure
- preparing trisubstituted
- imidazold
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH571580 | 1980-07-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK331881A true DK331881A (da) | 1982-01-26 |
Family
ID=4298165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK331881A DK331881A (da) | 1980-07-25 | 1981-07-24 | Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte deraf |
Country Status (23)
Country | Link |
---|---|
US (1) | US4447431A (da) |
EP (1) | EP0045081B1 (da) |
JP (1) | JPS5756466A (da) |
KR (13) | KR850000883B1 (da) |
AR (1) | AR230269A1 (da) |
AT (1) | ATE17349T1 (da) |
AU (2) | AU7340481A (da) |
CA (1) | CA1175431A (da) |
DD (2) | DD201677A5 (da) |
DE (1) | DE3173434D1 (da) |
DK (1) | DK331881A (da) |
ES (8) | ES8301472A1 (da) |
FI (1) | FI812326L (da) |
GB (1) | GB2080805B (da) |
GR (1) | GR75287B (da) |
IE (1) | IE52071B1 (da) |
IL (1) | IL63410A (da) |
NO (1) | NO812542L (da) |
NZ (1) | NZ197828A (da) |
PL (8) | PL237004A1 (da) |
PT (1) | PT73424B (da) |
SU (8) | SU1235454A3 (da) |
ZA (1) | ZA815078B (da) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2123831B (en) * | 1981-07-20 | 1986-01-15 | Ciba Geigy Ag | Trisubstituted oxazo compounds |
EP0084756A1 (de) * | 1982-01-22 | 1983-08-03 | Ciba-Geigy Ag | Trisubstituierte Oxazaverbindungen |
FR2633291B1 (fr) * | 1988-06-27 | 1990-09-07 | Oreal | Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant |
US5252322A (en) * | 1989-09-22 | 1993-10-12 | The Gillette Company | Skin tanning compositions containing imidazoles |
NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
US5916891A (en) * | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
US5670527A (en) * | 1993-07-16 | 1997-09-23 | Smithkline Beecham Corporation | Pyridyl imidazole compounds and compositions |
US5593991A (en) * | 1993-07-16 | 1997-01-14 | Adams; Jerry L. | Imidazole compounds, use and process of making |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
JPH09505055A (ja) * | 1993-11-08 | 1997-05-20 | スミスクライン・ビーチャム・コーポレイション | サイトカイン媒介疾患治療用オキサゾール |
US5723477A (en) * | 1994-11-10 | 1998-03-03 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US6369068B1 (en) | 1995-06-07 | 2002-04-09 | Smithkline Beecham Corporation | Amino substituted pyrimidine containing compounds |
IL118544A (en) | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
US5739143A (en) * | 1995-06-07 | 1998-04-14 | Smithkline Beecham Corporation | Imidazole compounds and compositions |
ZA9610687B (en) * | 1995-12-22 | 1997-09-29 | Smithkline Beecham Corp | Novel synthesis. |
AP9700912A0 (en) | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
ZA97175B (en) * | 1996-01-11 | 1997-11-04 | Smithkline Beecham Corp | Novel substituted imidazole compounds. |
CZ216498A3 (cs) * | 1996-01-11 | 1999-08-11 | Smithkline Beecham Corporation | Nové substituované imidazolové sloučeniny |
US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
EP0889888A4 (en) * | 1996-03-25 | 2003-01-08 | Smithkline Beecham Corp | NEW TREATMENT OF LESIONS IN THE CENTRAL NERVOUS SYSTEM |
EP0956018A4 (en) | 1996-08-21 | 2000-01-12 | Smithkline Beecham Corp | IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE |
US5929076A (en) * | 1997-01-10 | 1999-07-27 | Smithkline Beecham Corporation | Cycloalkyl substituted imidazoles |
EP1028954B1 (en) * | 1997-04-24 | 2003-07-02 | Ortho-McNeil Pharmaceutical, Inc. | Substituted imidazoles useful in the treatment of inflammatory diseases |
WO1998056377A1 (en) | 1997-06-13 | 1998-12-17 | Smithkline Beecham Corporation | Novel pyrazole and pyrazoline substituted compounds |
US6610695B1 (en) | 1997-06-19 | 2003-08-26 | Smithkline Beecham Corporation | Aryloxy substituted pyrimidine imidazole compounds |
US7301021B2 (en) * | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
TW517055B (en) | 1997-07-02 | 2003-01-11 | Smithkline Beecham Corp | Novel substituted imidazole compounds |
AR016294A1 (es) * | 1997-07-02 | 2001-07-04 | Smithkline Beecham Corp | Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion |
US6489325B1 (en) | 1998-07-01 | 2002-12-03 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US6562832B1 (en) | 1997-07-02 | 2003-05-13 | Smithkline Beecham Corporation | Substituted imidazole compounds |
WO1999001452A1 (en) | 1997-07-02 | 1999-01-14 | Smithkline Beecham Corporation | Novel cycloalkyl substituted imidazoles |
EP1041989A4 (en) | 1997-10-08 | 2002-11-20 | Smithkline Beecham Corp | NEW SUBSTITUTED CYCLOALCENYL COMPOUNDS |
EP1037639A4 (en) | 1997-12-19 | 2002-04-17 | Smithkline Beecham Corp | HETEROARYL-SUBSTITUTED IMIDAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES |
JP2002516322A (ja) * | 1998-05-22 | 2002-06-04 | スミスクライン・ビーチャム・コーポレイション | 新規2−アルキル置換イミダゾール化合物 |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
WO2000010563A1 (en) * | 1998-08-20 | 2000-03-02 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
JP2002528506A (ja) * | 1998-11-04 | 2002-09-03 | スミスクライン・ビーチャム・コーポレイション | ピリジン−4−イルまたはピリミジン−4−イル置換ピラジン |
WO2000029399A1 (en) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Antiherpes compounds |
US6239279B1 (en) | 1998-12-16 | 2001-05-29 | Smithkline Beecham Corporation | Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives |
BR0015532A (pt) | 1999-11-22 | 2002-06-25 | Smithkline Beecham Plc | Compostos |
EP1233951B1 (en) | 1999-11-23 | 2005-06-01 | SmithKline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
AU1781601A (en) | 1999-11-23 | 2001-06-04 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
US6982270B1 (en) | 1999-11-23 | 2006-01-03 | Smithkline Beecham Corporation | 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
US7235551B2 (en) * | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
GB0005357D0 (en) | 2000-03-06 | 2000-04-26 | Smithkline Beecham Plc | Compounds |
DE60103136T2 (de) * | 2000-03-06 | 2004-10-28 | Smithkline Beecham Plc, Brentford | Imidazolderivate als Raf-Kinase Inhibitoren |
MXPA03003612A (es) * | 2000-10-23 | 2003-06-19 | Smithkline Beecham Corp | Compuestos novedosos. |
GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
US20040192689A1 (en) * | 2001-09-05 | 2004-09-30 | Dean David Kenneth | Heterocycle-carboxamide derivatives as raf kinase inhibitors |
TW200505446A (en) * | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
KR20060007008A (ko) * | 2003-05-08 | 2006-01-23 | 아스텔라스세이야쿠 가부시키가이샤 | Cox 저해제 |
WO2006104917A2 (en) * | 2005-03-25 | 2006-10-05 | Glaxo Group Limited | Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives |
AR053346A1 (es) | 2005-03-25 | 2007-05-02 | Glaxo Group Ltd | Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38 |
WO2013049272A2 (en) | 2011-09-29 | 2013-04-04 | Theraceutix, Llc | Composition and method for treatment of symptoms associated with various skin conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558645A (en) * | 1968-07-08 | 1971-01-26 | Sandoz Ag | 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids |
CH561717A5 (da) * | 1971-05-10 | 1975-05-15 | Ciba Geigy Ag | |
GB1469532A (en) * | 1973-06-28 | 1977-04-06 | Dumex Ltd As | Imimdazolyl-alkanoic acid derivatives |
US4372964A (en) * | 1980-10-30 | 1983-02-08 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols |
-
1981
- 1981-07-23 GR GR65613A patent/GR75287B/el unknown
- 1981-07-23 CA CA000382377A patent/CA1175431A/en not_active Expired
- 1981-07-23 DD DD81232030A patent/DD201677A5/de unknown
- 1981-07-24 NZ NZ197828A patent/NZ197828A/en unknown
- 1981-07-24 FI FI812326A patent/FI812326L/fi not_active Application Discontinuation
- 1981-07-24 PT PT73424A patent/PT73424B/pt unknown
- 1981-07-24 AU AU73404/81A patent/AU7340481A/en not_active Abandoned
- 1981-07-24 GB GB8122920A patent/GB2080805B/en not_active Expired
- 1981-07-24 DK DK331881A patent/DK331881A/da not_active Application Discontinuation
- 1981-07-24 ES ES504257A patent/ES8301472A1/es not_active Expired
- 1981-07-24 NO NO812542A patent/NO812542L/no unknown
- 1981-07-24 IL IL63410A patent/IL63410A/xx unknown
- 1981-07-24 SU SU813317053A patent/SU1235454A3/ru active
- 1981-07-24 ZA ZA815078A patent/ZA815078B/xx unknown
- 1981-07-24 IE IE1680/81A patent/IE52071B1/en unknown
- 1981-07-25 PL PL23700481A patent/PL237004A1/xx unknown
- 1981-07-25 JP JP56115896A patent/JPS5756466A/ja active Pending
- 1981-07-25 PL PL1981232352A patent/PL135822B1/pl unknown
- 1981-07-25 PL PL23700281A patent/PL237002A1/xx unknown
- 1981-07-25 PL PL23700381A patent/PL237003A1/xx unknown
- 1981-07-25 PL PL23700181A patent/PL237001A1/xx unknown
- 1981-07-25 KR KR1019810002709A patent/KR850000883B1/ko active
- 1981-07-25 PL PL23699781A patent/PL236997A1/xx unknown
- 1981-07-25 PL PL23700581A patent/PL237005A1/xx unknown
- 1981-07-25 PL PL23700081A patent/PL237000A1/xx unknown
- 1981-07-27 EP EP81105914A patent/EP0045081B1/de not_active Expired
- 1981-07-27 DE DE8181105914T patent/DE3173434D1/de not_active Expired
- 1981-07-27 AT AT81105914T patent/ATE17349T1/de not_active IP Right Cessation
-
1982
- 1982-07-21 SU SU823465351A patent/SU1138023A3/ru active
- 1982-07-21 SU SU823466066A patent/SU1145928A3/ru active
- 1982-07-21 SU SU823465356A patent/SU1205764A3/ru active
- 1982-07-21 SU SU823466067A patent/SU1227112A3/ru active
- 1982-07-30 ES ES514583A patent/ES8306123A1/es not_active Expired
- 1982-07-30 ES ES514581A patent/ES514581A0/es active Granted
- 1982-07-30 ES ES514585A patent/ES514585A0/es active Granted
- 1982-07-30 ES ES514582A patent/ES514582A0/es active Granted
- 1982-07-30 SU SU823468675A patent/SU1169534A3/ru active
- 1982-07-30 DD DD82242110A patent/DD202554A5/de unknown
- 1982-07-30 ES ES514579A patent/ES8306119A1/es not_active Expired
- 1982-07-30 ES ES514584A patent/ES8306124A1/es not_active Expired
- 1982-07-30 SU SU823469534A patent/SU1152520A3/ru active
- 1982-07-30 ES ES514580A patent/ES514580A0/es active Granted
- 1982-09-28 US US06/425,603 patent/US4447431A/en not_active Expired - Fee Related
- 1982-11-22 AR AR291374A patent/AR230269A1/es active
-
1983
- 1983-07-19 SU SU833618708A patent/SU1205763A3/ru active
-
1984
- 1984-09-27 KR KR1019840005964A patent/KR850000887B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005971A patent/KR850000892B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005970A patent/KR850000911B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005969A patent/KR850000891B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005968A patent/KR850000890B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005972A patent/KR850001064B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005961A patent/KR850000884B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005962A patent/KR850000885B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005963A patent/KR850000886B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005960A patent/KR850000873B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005965A patent/KR850000888B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005966A patent/KR850000889B1/ko active IP Right Grant
-
1986
- 1986-04-23 AU AU56555/86A patent/AU5655586A/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK331881A (da) | Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte deraf | |
DK28282A (da) | Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf | |
DK405881A (da) | Fremgangsmaade til fremstilling af 7beta-aminothiadiazolylacetylamino3-ammoniomethyl-3-cephem-4-carboxylsyreforbindelser eller salte deraf | |
DK552581A (da) | Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf | |
DK483681A (da) | Fremgangsmaade til fremstilling af 1-carboxy-(azaalkanoyl eller azaaralkanoyl)-indolin-2-carboxylsyrer eller salte deraf | |
DK503080A (da) | Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf | |
DK294780A (da) | Fremgangsmaade til fremstilling af trans-3-(4-oxo4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf | |
DK273479A (da) | Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf | |
DK118482A (da) | Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf | |
DK358183D0 (da) | Fremgangsmade til fremstilling af alfa-aryl-alkansyrer eller salte deraf | |
DK324979A (da) | Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf | |
DK475982A (da) | Fremgangsmaade til fremstilling af benzofuranoner eller salte deraf | |
DK161310C (da) | Analogifremgangsmaade til fremstilling af aminopropoxyphenylderivater | |
DK365980A (da) | Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf | |
DK495780A (da) | Fremgangsmaade til fremstilling af 2-keto-l-gulonsyre eller salte deraf | |
DK223177A (da) | Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf | |
DK115379A (da) | Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf | |
DK152674C (da) | Analogifremgangsmaade til fremstilling af 3-metyltiometyl-4-oxo-quinolonderivater | |
DK366081A (da) | Fremgangsmaade til fremstilling af diaryl-imidazol-forbindelser eller salte deraf | |
DK224381A (da) | Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf | |
DK160043C (da) | Analogifremgangsmaade til fremstilling af n-alk-2-en-4-yn-yl-benzothienylalkylaminer eller syreadditionssalte deraf | |
DK300280A (da) | Fremgangsmaade til fremstilling af tetrahydropyridin-4-ylindolderivater eller salte deraf | |
DK152501C (da) | Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf | |
DK432582A (da) | Fremgangsmaade til fremstilling af aminooxazolylforbindelser eller salte deraf | |
DK149823C (da) | Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |